Physician

George V Kuttickat, MD

According to 2025 Medicare claims, George Kuttickat, MD (NPI: 1447367982) practices cardiology in the Sheboygan, WI market, with the plurality of this provider's patient population coming from Sheboygan, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 53081-8426. Kuttickat is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Kuttickat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,190 traditional Medicare patients, billed 6,945 HCPCS/CPT codes, and received $295,580 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 16,190 prescription claims across 1,547 beneficiaries totaling $2,911,360 in drug costs, led by Eliquis (Apixaban). DME data shows 70 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $307,984 to $2,911,360. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $618 to $31,259.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,321	8,893	$358,463
2016	1,269	7,615	$371,429
2017	1,223	6,264	$369,064
2018	1,366	6,480	$318,999
2019	1,467	6,895	$314,553
2020	1,280	6,968	$295,619
2021	1,375	7,739	$346,958
2022	1,351	7,515	$345,602
2023	1,267	7,029	$297,939
2024	1,190	6,945	$295,580

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	899	11,180	$307,984
2016	933	11,486	$329,134
2017	1,033	11,694	$445,797
2018	1,235	13,192	$638,607
2019	1,333	13,810	$675,327
2020	1,370	13,653	$814,952
2021	1,394	13,758	$1,262,331
2022	1,403	14,068	$1,560,980
2023	1,434	14,771	$2,128,883
2024	1,547	16,190	$2,911,360

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$25,600
2024	N/R	70	$30,592

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	455	463	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	210	253	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	321	349	$58
93356	Heart muscle strain imaging	378	393	$21
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	499	558	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	993	56,452	$1,079,046
Jardiance	Empagliflozin	623	31,483	$609,835
Entresto	Sacubitril/Valsartan	338	17,873	$394,761
Vyndamax	Tafamidis	13	390	$256,447
Xarelto	Rivaroxaban	174	10,963	$199,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	12	$28,959
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	12	$799
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	20	$556
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	26	$278

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for George V. Kuttickat, MD?

Tedicare shows public-source Medicare data for George V. Kuttickat, MD (NPI 1447367982), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George V. Kuttickat, MD have ACO affiliation data?

George V. Kuttickat, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to George V. Kuttickat, MD?

George V. Kuttickat, MD is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does George V. Kuttickat, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.